Necrotizing Enterocolitis: Clinical Trials

5 trials for Necrotizing Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 31Unknown 1

Follow Necrotizing Enterocolitis: new trials by email Literature Review of Necrotizing Enterocolitis trials Research Report on Necrotizing Enterocolitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants
Lactobacillus Reuteri DSM 17938, Placebo - Necrotizing Enterocolitis, Sepsis
Phase 2UnknownChildren's Hospital and Institute of Child Health, Multan1202020-10-012020-09-09
Heat Killed Probiotics in the Prevention of Necrotizing Enterocolitis
Heat Inactivated probiotics, Placebo - Necrotizing Enterocolitis, Enterocolitis, Necrotizing
Phase 2UnknownShaare Zedek Medical Center4502016-06-012016-06-16
Prebiotics in the Prevention of Necrotizing Enterocolitis
Galacto-oligosaccharide (GOS), Placebo - Necrotizing Enterocolitis
Phase 2UnknownShaare Zedek Medical Center2602009-07-012014-01-03
Cysteine Supplementation in Critically Ill Neonates
Parenteral cysteine-HCl supplementation, Placebo - added premasol - Sepsis, Bronchopulmonary Dysplasia
Phase 2 / Phase 3UnknownUniversity of California, Los Angeles1082006-09-012010-02-26
Pentoxifylline in the Treatment of NEC in Premature Neonates
Pentoxifylline - Necrotizing Enterocolitis
Phase 2UnknownShaare Zedek Medical Center502005-01-012008-05-23

Narrower conditions

Enterocolitis, Necrotizing (5)  ·  Sepsis (2)  ·  Bronchopulmonary Dysplasia (1)  ·  Premature Birth (1)  ·  Retinopathy of Prematurity (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Digestive System Diseases (5)  ·  Enterocolitis (5)  ·  Gastroenteritis (5)  ·  Gastrointestinal Diseases (5)  ·  Intestinal Diseases (5)  ·  Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Infant, Newborn, Diseases (1)  ·  Infant, Premature, Diseases (1)  ·  Lung Diseases (1)

Interventions

4'-galactooligosaccharide (1)  ·  Pentoxifylline (1)  ·  amino-acid, glucose, and electrolyte solution (1)

Sponsors

Shaare Zedek Medical Center (3)  ·  Children's Hospital and Institute of Child Health, Multan (1)  ·  University of California, Los Angeles (1)

Countries

Israel (3)  ·  United States (1)

Top investigators

Cathy Hammerman, MD (3)  ·  Stephen B Shew, M.D. (1)

Results publications

PMID 33006765

NIH funding

K08HD052885 (1)